Novel Piperidine-Substituted Indoles
    1.
    发明申请
    Novel Piperidine-Substituted Indoles 有权
    新型哌啶取代的吲哚

    公开(公告)号:US20060247230A1

    公开(公告)日:2006-11-02

    申请号:US11380232

    申请日:2006-04-26

    CPC分类号: C07D401/04

    摘要: Disclosed are novel piperidine-substituted indoles- or heteroderivatives thereof of the formula 1: wherein R1, R5, R6, R7, A, B, D-E, Y, i, j, n and m are defined as below. The compounds of formula 1 are useful as agonists or antagonists of CCR-3. The present invention is also directed to pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.

    摘要翻译: 公开了式1的新的哌啶取代的吲哚或其异构衍生物:其中R 1,R 5,R 6,R SUP > 7 ,A,B,DE,Y,i,j,n和m定义如下。 式1的化合物可用作CCR-3的激动剂或拮抗剂。 本发明还涉及其药学上可接受的盐,更特别的是提供药物组合物,其包含药学上可接受的载体和治疗有效量的至少一种本发明的化合物或其药学上可接受的盐。

    Piperidine-substituted indoles
    2.
    发明授权
    Piperidine-substituted indoles 有权
    哌啶取代的吲哚

    公开(公告)号:US07759365B2

    公开(公告)日:2010-07-20

    申请号:US11380232

    申请日:2006-04-26

    IPC分类号: A61K31/454 C07D403/14

    CPC分类号: C07D401/04

    摘要: Disclosed are novel piperidine-substituted indoles- or heteroderivatives thereof of the formula 1: wherein R1, R5, R6, R7, A, B, D-E, Y, i, j, n and m are defined as below. The compounds of formula 1 are useful as agonists or antagonists of CCR-3. The present invention is also directed to pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.

    摘要翻译: 公开了式1的新的哌啶取代的吲哚或其异构衍生物:其中R1,R5,R6,R7,A,B,D-E,Y,i,j,n和m如下定义。 式1的化合物可用作CCR-3的激动剂或拮抗剂。 本发明还涉及其药学上可接受的盐,更特别的是提供药物组合物,其包含药学上可接受的载体和治疗有效量的至少一种本发明的化合物或其药学上可接受的盐。

    Substituted piperidyl-propane-thiols
    7.
    发明授权
    Substituted piperidyl-propane-thiols 有权
    取代的哌啶基 - 丙烷 - 硫醇

    公开(公告)号:US08148403B2

    公开(公告)日:2012-04-03

    申请号:US12446001

    申请日:2007-10-25

    IPC分类号: A61K31/445 C07D401/00

    摘要: One object of the present invention are novel substituted piperidyl-propane-thiols of the formula (1), wherein R1, R2, R3 and D are defined as below. Another object of the present invention is to provide agonists or antagonists of CCR-3, or pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明的一个目的是式(1)的新的取代的哌啶基 - 丙烷 - 硫醇,其中R1,R2,R3和D定义如下。 本发明的另一个目的是提供CCR-3的激动剂或拮抗剂或其药学上可接受的盐,更具体地提供药物组合物,其包含药学上可接受的载体和治疗有效量的至少一种本发明的化合物 或其药学上可接受的盐。

    Piperidyl-propane-thiol CCR3 modulators
    9.
    发明授权
    Piperidyl-propane-thiol CCR3 modulators 有权
    哌啶基 - 丙烷 - 硫醇CCR3调节剂

    公开(公告)号:US08153660B2

    公开(公告)日:2012-04-10

    申请号:US12445993

    申请日:2007-10-25

    IPC分类号: A61K31/445 C07D401/00

    CPC分类号: C07D401/04 C07D401/14

    摘要: One object of the present invention are novel substituted piperidyl-propane-thiols of the formula (1), wherein R1, R2, R3 and R4 are defined as below. Another object of the present invention is to provide agonists or antagonists of CCR-3, or pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明的一个目的是式(1)的新的取代的哌啶基 - 丙烷 - 硫醇,其中R1,R2,R3和R4定义如下。 本发明的另一个目的是提供CCR-3的激动剂或拮抗剂或其药学上可接受的盐,更具体地提供药物组合物,其包含药学上可接受的载体和治疗有效量的至少一种本发明的化合物 或其药学上可接受的盐。